Protalix BioTherapeutics
PLX
#8915
Rank
โ‚น12.50 B
Marketcap
โ‚น155.52
Share price
-1.14%
Change (1 day)
4.37%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: โ‚น12.50 Billion

As of December 2025 Protalix BioTherapeutics has a market cap of โ‚น12.50 Billion. This makes Protalix BioTherapeutics the world's 8915th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น12.50 B8.2%
2024โ‚น11.55 B6.93%
2023โ‚น10.81 B88.21%
2022โ‚น5.74 B103.67%
2021โ‚น2.82 B-68.13%
2020โ‚น8.85 B155%
2019โ‚น3.47 B7.56%
2018โ‚น3.22 B-45.3%
2017โ‚น5.89 B57.6%
2016โ‚น3.74 B-44.67%
2015โ‚น6.76 B-38.03%
2014โ‚น10.91 B-51.42%
2013โ‚น22.46 B-15.43%
2012โ‚น26.56 B18.97%
2011โ‚น22.33 B-38.23%
2010โ‚น36.15 B45.59%
2009โ‚น24.83 B269.78%
2008โ‚น6.71 B-33.58%
2007โ‚น10.11 B-77.87%
2006โ‚น45.69 B3997.82%
2005โ‚น1.11 B4316.04%
2004โ‚น25.25 M-52.44%
2003โ‚น53.09 M245.25%
2002โ‚น15.37 M-52.47%
2001โ‚น32.35 M-5.75%
2000โ‚น34.33 M-1.06%
1999โ‚น34.69 M-85.72%
1998โ‚น0.24 B-73.05%
1997โ‚น0.90 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Protalix BioTherapeutics was reported to be:

โ‚น12.50 Billion
by Nasdaq info icon info icon
โ‚น12.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amicus Therapeutics
FOLD
โ‚น274.58 B 2,095.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.393 T 11,044.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.304 T 106,275.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น2.935 T 23,368.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel